1,373
Views
60
CrossRef citations to date
0
Altmetric
Review Article

Carbonyl reduction pathways in drug metabolism

&
Pages 96-123 | Received 08 Aug 2013, Accepted 03 Oct 2013, Published online: 31 Oct 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jing Gu, Zheng Sui, Chunshu Fang & Qunyou Tan. (2017) Stereochemical considerations in pharmacokinetic processes of representative antineoplastic agents. Drug Metabolism Reviews 49:4, pages 438-450.
Read now
Sophia M. Shi & Li Di. (2017) The role of carbonyl reductase 1 in drug discovery and development. Expert Opinion on Drug Metabolism & Toxicology 13:8, pages 859-870.
Read now
Bettina Ebert, Michael Kisiela & Edmund Maser. (2016) Transcriptional regulation of human and murine short-chain dehydrogenase/reductases (SDRs) – an in silico approach. Drug Metabolism Reviews 48:2, pages 183-217.
Read now
Iva Boušová, Lenka Skálová, Pavel Souček & Petra Matoušková. (2015) The modulation of carbonyl reductase 1 by polyphenols. Drug Metabolism Reviews 47:4, pages 520-533.
Read now

Articles from other publishers (56)

Satabdi Bera, Subhenira Jana & Rajarshi Samanta. (2023) Recent Progress on Copper-Catalyzed C–C Bond Formation via C(sp2)–H Insertions Using Diazo and Related Compounds. Synthesis 56:01, pages 29-46.
Crossref
Keiya Hirosawa, Hijiri Fujioka, Gaku Morinaga, Tatsuki Fukami, Naoki Ishiguro, Wataru Kishimoto, Hiroshi Nakase, Hiroyuki Mizuguchi & Miki Nakajima. (2023) Quantitative Analysis of mRNA and Protein Expression Levels of Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoforms in the Human Intestine. Drug Metabolism and Disposition 51:12, pages 1569-1577.
Crossref
Daniels Jelisejevs, Anna Lina Bula & Linda Kinena. (2023) Pyrazolidinone-based peptidomimetic SARS-CoV-2 Mpro inhibitors. Bioorganic & Medicinal Chemistry Letters 96, pages 129530.
Crossref
Faridoon, Raymond Ng, Guiping Zhang & Jie Jack Li. (2023) An update on the discovery and development of reversible covalent inhibitors. Medicinal Chemistry Research 32:6, pages 1039-1062.
Crossref
Hiroyuki Ichida, Tatsuki Fukami, Takashi Kudo, Kenji Mishiro, Shiori Takano, Masataka Nakano, Gaku Morinaga, Akiko Matsui, Naoki Ishiguro & Miki Nakajima. (2023) Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolism. Archives of Biochemistry and Biophysics 736, pages 109536.
Crossref
Kristina Shutevska, Zoran Zhivikj, Aleksandar Dimkovski, Nikola Geshkovski, Tanja Petreska Ivanovska, Tatjana Kadifkova Panovska & Aleksandra Kapedanovska Nestorovska. (2022) The importance of AKR1D1 enzyme in drug metabolism. Macedonian Pharmaceutical Bulletin 68:03, pages 323-324.
Crossref
Chenxin Ge, Bin Wang, Yunchen Jiang & Chao Chen. (2022) Diverse reactivity of the gem-difluorovinyl iodonium salt for direct incorporation of the difluoroethylene group into N- and O-nucleophiles. Communications Chemistry 5:1.
Crossref
Banerjee Riddhidev, Karaj Endri, Lamichhane Sabitri, N. Kotsull, Lauren, Kuganesan Nishanth, Isailovic Dragan, Pflum Mary Kay H, Slama James, Taylor William & Tillekeratne L. M. Viranga. (2022) Rational design of metabolically stable HDAC inhibitors: An overhaul of trifluoromethyl ketones. European Journal of Medicinal Chemistry 244, pages 114807.
Crossref
Liangyu Qian, Huanrong Ouyang, Lois Gordils-Valentin, Joshua Hong, Arul Jayaraman & Xuejun Zhu. (2022) Identification of Gut Bacterial Enzymes for Keto-Reductive Metabolism of Xenobiotics. ACS Chemical Biology 17:7, pages 1665-1671.
Crossref
Dakota L. Pouncey, Dustyn A. Barnette, Riley W. Sinnott, Sarah J. Phillips, Noah R. Flynn, Howard P. Hendrickson, S. Joshua Swamidass & Grover P. Miller. (2022) Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin. Frontiers in Pharmacology 12.
Crossref
Rachel Ryu & Mary F. Hebert. 2022. Clinical Pharmacology During Pregnancy. Clinical Pharmacology During Pregnancy 19 46 .
Antonia Genath, Hannes Petruschke, Martin von Bergen & Ralf Einspanier. (2021) Influence of formic acid treatment on the proteome of the ectoparasite Varroa destructor. PLOS ONE 16:10, pages e0258845.
Crossref
Donald J. AbrahamDeepak K. Dalvie & Bernard Testa. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 139 .
Bingnan Du, Chun-Ming Chan, Pui-Yiu Lee, Leong-Hung Cheung, Xin Xu, Zhenyang Lin & Wing-Yiu Yu. (2021) 2,2-difluorovinyl benzoates for diverse synthesis of gem-difluoroenol ethers by Ni-catalyzed cross-coupling reactions. Nature Communications 12:1.
Crossref
Anselm Morell, Eva Novotná, Jaroslav Milan, Petra Danielisová, Neslihan Büküm & Vladimír Wsól. (2020) Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism. Archives of Toxicology 95:1, pages 67-78.
Crossref
Margarita Valero, Peter P. Levin, Natalya B. Sultimova & Judith E. Houston. (2020) Photochemistry of nabumetone in aqueous solution of sodium dodecyl sulfate (SDS) micelles. Journal of Molecular Liquids 319, pages 114093.
Crossref
Vinicius Bonatto, Pedro Henrique Jatai Batista, Lorenzo Cianni, Daniela De Vita, Daniel G. Silva, Rodrigo Cedron, Daiane Y. Tezuka, Sérgio de Albuquerque, Carolina Borsoi Moraes, Caio Haddad Franco, Jerônimo Lameira, Andrei Leitão & Carlos A. Montanari. (2020) On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors. RSC Medicinal Chemistry 11:11, pages 1275-1284.
Crossref
Tássia S. Tavares, Jakub Hofman, Alžběta Lekešová, Jana Želazková & Vladimír Wsól. (2020) Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3. Cancers 12:11, pages 3127.
Crossref
Zhen Yang, Chao Pei & Rene M. Koenigs. (2020) Access to gem -Difluoro Olefins via C–H Functionalization and Dual Role of Anilines . Organic Letters 22:18, pages 7234-7238.
Crossref
Ales Sorf, Simona Sucha, Anselm Morell, Eva Novotna, Frantisek Staud, Alzbeta Zavrelova, Benjamin Visek, Vladimir Wsol & Martina Ceckova. (2020) Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors. Cancers 12:6, pages 1596.
Crossref
Andrés Sauvêtre, Peter Eichhorn & Sandra Pérez. 2021. Interaction and Fate of Pharmaceuticals in Soil-Crop Systems. Interaction and Fate of Pharmaceuticals in Soil-Crop Systems 221 264 .
Min Chen, Baozhang Guan, Haiman Xu, Fangjun Yu, Tianpeng Zhang & Baojian Wu. (2019) The Molecular Mechanism Regulating Diurnal Rhythm of Flavin-Containing Monooxygenase 5 in Mouse Liver. Drug Metabolism and Disposition 47:11, pages 1333-1342.
Crossref
Wei Luo, Hui-Jun Du, Emmanuel Mintah Bonku, Ya-Li Hou, Ling-Ling Li, Xiao-Qiang Wang & Zhong-Hua Yang. (2019) An Alkali-tolerant Carbonyl Reductase from Bacillus subtilis by Gene Mining: Identification and Application. Catalysis Letters 149:11, pages 2973-2983.
Crossref
Jennifer S. Strehse, Nikolaos Protopapas & Edmund Maser. (2019) Carbonyl reductase sniffer from the model organism daphnia: Cloning, substrate determination and inhibitory sensitivity. Chemico-Biological Interactions 307, pages 29-36.
Crossref
Rebecca J. Wiles, James P. Phelan & Gary A. Molander. (2019) Metal-free defluorinative arylation of trifluoromethyl alkenes via photoredox catalysis . Chemical Communications 55:53, pages 7599-7602.
Crossref
Matthias Gehringer & Stefan A. Laufer. (2018) Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. Journal of Medicinal Chemistry 62:12, pages 5673-5724.
Crossref
Jan Moritz Seliger, Hans-Jörg Martin, Edmund Maser & Jan Hintzpeter. (2019) Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin. Chemico-Biological Interactions 305, pages 156-162.
Crossref
Haoguo Chen, Devireddy Anand & Lei Zhou. (2019) Photoredox Defluorinative Alkylation of 1‐Trifluoromethyl Alkenes and 1,3‐Butadienes with 1,4‐Dihydropyridines as Alkylation Reagents. Asian Journal of Organic Chemistry 8:5, pages 661-664.
Crossref
Kamil Uney, Bunyamin Tras, Orhan Corum, Ramazan Yildiz & Mehmet Maden. (2018) Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite following intravenous administration in cattle. Tropical Animal Health and Production 51:2, pages 435-441.
Crossref
Diane Ramsden, Dustin Smith, Raquel Arenas, Kosea Frederick & Matthew A. Cerny. (2018) Identification and Characterization of a Selective Human Carbonyl Reductase 1 Substrate. Drug Metabolism and Disposition 46:10, pages 1434-1440.
Crossref
Bettina Ebert, Dieter Ebert, Katrin Koebsch, Edmund Maser & Michael Kisiela. (2018) Carbonyl reductases from Daphnia are regulated by redox cycling compounds . The FEBS Journal 285:15, pages 2869-2887.
Crossref
Minyan Wang, Xinghui Pu, Yunfei Zhao, Panpan Wang, Zexian Li, Chendan Zhu & Zhuangzhi Shi. (2018) Enantioselective Copper-Catalyzed Defluoroalkylation Using Arylboronate-Activated Alkyl Grignard Reagents. Journal of the American Chemical Society 140:29, pages 9061-9065.
Crossref
Xin Yang, Wenyi Hua, Sangwoo Ryu, Phillip Yates, Cheng Chang, Hui Zhang & Li Di. (2018) 11 β -Hydroxysteroid Dehydrogenase 1 Human Tissue Distribution, Selective Inhibitor, and Role in Doxorubicin Metabolism . Drug Metabolism and Disposition 46:7, pages 1023-1029.
Crossref
Aleksandra Kapedanovska Nestorovska, Zorica Naumovska, Krume Jakovski, Zoran Sterjev, Nadica Matevska Geskovska, Aleksandar Dimovski & Ljubica Suturkova. (2018) Allele frequency and genotype distribution of aldo keto reductase 1D1 (AKR1D1) rs1872930 genetic variant in a Macedonian population. Macedonian Pharmaceutical Bulletin 64:01, pages 57-62.
Crossref
Yi Jiang, Jie-dan Deng, Hui-hong Wang, Jiao-xia Zou, Yong-qiang Wang, Jin-hong Chen, Long-qing Zhu, Hong-hua Zhang, Xue Peng & Zhen Wang. (2018) Direct access to α-sulfenylated amides/esters via sequential oxidative sulfenylation and C–C bond cleavage of 3-oxobutyric amides/esters . Chemical Communications 54:7, pages 802-805.
Crossref
Simon B. Lang, Rebecca J. Wiles, Christopher B. Kelly & Gary A. Molander. (2017) Photoredox Generation of Carbon-Centered Radicals Enables the Construction of 1,1-Difluoroalkene Carbonyl Mimics. Angewandte Chemie International Edition 56:47, pages 15073-15077.
Crossref
Simon B. Lang, Rebecca J. Wiles, Christopher B. Kelly & Gary A. Molander. (2017) Photoredox Generation of Carbon-Centered Radicals Enables the Construction of 1,1-Difluoroalkene Carbonyl Mimics. Angewandte Chemie 129:47, pages 15269-15273.
Crossref
Akira Hara, Satoshi Endo, Toshiyuki Matsunaga, Midori Soda, Koji Yashiro & Ossama El-Kabbani. (2017) Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily. The Journal of Biochemistry 162:5, pages 371-379.
Crossref
Petra Malátková, Adam Skarka, Kateřina Musilová & Vladimír Wsól. (2017) Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes. Chemico-Biological Interactions 276, pages 121-126.
Crossref
Christine Loerz, Claudia Staab-Weijnitz, Patricia Huebbe, Katrin Giller, Cornelia Metges, Gerald Rimbach & Edmund Maser. (2017) Regulation of 11β-hydroxysteroid dehydrogenase type 1 following caloric restriction and re-feeding is species dependent. Chemico-Biological Interactions 276, pages 95-104.
Crossref
Satoshi Endo, Sayaka Takada, Ryo P. Honda, Kathrin Müller, Jochen H. Weishaupt, Peter M. Andersen, Albert C. Ludolph, Yuji O. Kamatari, Toshiyuki Matsunaga, Kazuo Kuwata, Ossama El-Kabbani & Akira Ikari. (2017) Instability of C154Y variant of aldo-keto reductase 1C3. Chemico-Biological Interactions 276, pages 194-202.
Crossref
Dustyn A. Barnette, Bryce P. Johnson, Dakota L. Pouncey, Robert Nshimiyimana, Linda P. Desrochers, Thomas E. Goodwin & Grover P. Miller. (2017) Stereospecific Metabolism of R - and S -Warfarin by Human Hepatic Cytosolic Reductases . Drug Metabolism and Disposition 45:9, pages 1000-1007.
Crossref
Akira Hara, Satoshi Endo, Toshiyuki Matsunaga, Ossama El-Kabbani, Takeshi Miura, Toru Nishinaka & Tomoyuki Terada. (2017) Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs. Biochemical Pharmacology 138, pages 185-192.
Crossref
Shanshan Li, Xiaozhen Teng, Li Su, Guannan Mao, Yueyang Xu, Tingting Li, Riuhua Liu, Qionglin Zhang, Yingying Wang & Mark Bartlam. (2017) Structure and characterization of a NAD(P)H-dependent carbonyl reductase from Pseudomonas aeruginosa PAO1 . FEBS Letters 591:12, pages 1785-1797.
Crossref
Wenyi Hua, Hui Zhang, Sangwoo Ryu, Xin Yang & Li Di. (2017) Human Tissue Distribution of Carbonyl Reductase 1 Using Proteomic Approach With Liquid Chromatography-Tandem Mass Spectrometry. Journal of Pharmaceutical Sciences 106:5, pages 1405-1411.
Crossref
Alena Špičáková, Barbora Szotáková, Diana Dimunová, Zuzana Myslivečková, Vladimír Kubíček, Martin Ambrož, Kateřina Lněničková, Kristýna Krasulová, Pavel Anzenbacher & Lenka Skálová. (2017) Nerolidol and Farnesol Inhibit Some Cytochrome P450 Activities but Did Not Affect Other Xenobiotic-Metabolizing Enzymes in Rat and Human Hepatic Subcellular Fractions. Molecules 22:4, pages 509.
Crossref
T.D. Nolin. 2017. Drug Metabolism in Diseases. Drug Metabolism in Diseases 91 113 .
Petra Malátková, Matthildi Kanavi, Milan Nobilis & Vladimír Wsól. (2016) In vitro metabolism of fenofibric acid by carbonyl reducing enzymes. Chemico-Biological Interactions 258, pages 153-158.
Crossref
Michael R. Wood, Meredith J. Noetzel, James C. Tarr, Alice L. Rodriguez, Atin Lamsal, Sichen Chang, Jarrett J. Foster, Emery Smith, Peter Chase, Peter S. Hodder, Darren W. Engers, Colleen M. Niswender, Nicholas J. Brandon, Michael W. Wood, Mark E. Duggan, P. Jeffrey Conn, Thomas M. Bridges & Craig W. Lindsley. (2016) Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition. Bioorganic & Medicinal Chemistry Letters 26:17, pages 4282-4286.
Crossref
R. S. Foti & D. K. Dalvie. (2016) Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics. Drug Metabolism and Disposition 44:8, pages 1229-1245.
Crossref
Petra Malátková, Simona Sokolová, Lucie Chocholoušová Havlíková & Vladimír Wsól. (2016) Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases. Biochemical Pharmacology 109, pages 83-90.
Crossref
Qingnan Liang, Rui Liu, Shuqi Du & Yu Ding. (2015) Structural insights on the catalytic site protection of human carbonyl reductase 1 by glutathione. Journal of Structural Biology 192:1, pages 138-144.
Crossref
Alex Odermatt & Petra Klusonova. (2015) 11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story. The Journal of Steroid Biochemistry and Molecular Biology 151, pages 85-92.
Crossref
Osama Y. Alshogran, Judith Naud, Andrew J. Ocque, François A. Leblond, Vincent Pichette & Thomas D. Nolin. (2015) Effect of Experimental Kidney Disease on the Functional Expression of Hepatic Reductases. Drug Metabolism and Disposition 43:1, pages 100-106.
Crossref
Bernard Testa & Bernd Clement. 2015. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry 561 584 .
Petra Malátková, Lucie Havlíková & Vladimír Wsól. (2014) The role of carbonyl reducing enzymes in oxcarbazepine in vitro metabolism in man. Chemico-Biological Interactions 220, pages 241-247.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.